je.st
news
Tag: fda
August's top stories: Vitro secures $950m contract, FDA tightens gluten-free labelling rules
2014-09-08 12:58:00| Packaging Gateway
Philip Morris International plans to sue the UK Government if it goes ahead with the implementation of the proposed law that requires plain packaging for cigarettes, while the US FDA has tightened gluten-free labelling rules. Packaging Gateway wraps-
Tags: top
rules
stories
contract
New Microbes, Toxins Discovered In NIH, FDA Lab...
2014-09-07 16:14:11| Biotech - Topix.net
Containers filled with several types of potentially deadly substances, including a nearly 100-year-old vial of the toxin ricin and samples of the pathogens that cause botulism and the plague , have reportedly been discovered at US National Institutes of Health and Food and Drug Administration laboratories. The substances were discovered as part of a search launched in response to the accidental discovery of smallpox at an NIH facility in Bethesda, Maryland earlier this summer, according to BBC News .
Tags: discovered
lab
nih
fda
Six more deadly pathogens discovered improperly stored in NIH and FDA labs
2014-09-06 10:52:18| Biotech - Topix.net
Workers searching government laboratories in the wake of the July discovery of smallpox have found six more improperly stored, dangerous pathogens - including ricin, the neurotoxin botulism and the bacteria that causes plague. On Friday, officials at the National Institutes of Health said the search on its sprawling Bethesda campus had turned up five different misplaced pathogens in recent weeks.
Tags: stored
discovered
labs
nih
FDA OKs Merck drug for melanoma, 1st in new cancer drug class
2014-09-04 23:14:34| Biotech - Topix.net
Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments.
Mercks Investigational Beta-lactamase Inhibitor Relebactam (MK-7655) Granted Qualified Infectious Disease Product (QIDP) and Fast Track Designations by FDA
2014-09-04 15:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated relebactam (previously known as MK-7655), the companys investigational beta-lactamase inhibitor, as a Qualified Infectious Disease Product (QIDP) with designated Fast Track status. Language: English Contact: Media:Caroline Lappetito, 267-305-7639orRobert Consalvo, 908-423-6595orInvestors:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: product
fast
track
disease
Sites : [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] next »